Grant of options
Faron Pharmaceuticals Ltd (“Faron” or the “Company”) Grant of options Company announcement, December 4, 2023 at 9 am (EET) / 7 am (GMT) TURKU, FINLAND / BOSTON, MA - Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical stage biopharmaceutical company focused on building the future of immunotherapy by harnessing the power of the immune system to tackle cancer and inflammation, today announces that the Company’s board has confirmed the grant of a total of 34,000 options over ordinary shares in the Company (“Options”) under the Company’s Share Option Plan 2019 (